13F HOLDINGS REPORT
TRV GP V, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001193125-26-051785
Total Value
$429.2M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RAPPORT THERAPEUTICS, INC. | RAPP | 7,135,233 | $216.5M | 50.44% |
| 2 | SEPTERNA, INC. | SEPN | 6,215,591 | $173.3M | 40.38% |
| 3 | MAZE THERAPEUTICS, INC. | MAZE | 950,800 | $39.4M | 9.18% |